Key facts
- This page summarizes Pat Beyer's Form 4 filing for CONMED Corp (CNMD).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 02 Apr 2026, 16:05.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
On March 23rd, 2026, the CONMED Board of Directors approved an additional equity award for the CEO of $1M in target value to be granted in the form of RSUs and scheduled to vest starting April 1st, 2026 over 3-years in three equal annual tranches with a 2-year post-vest holding period to be applied to net after tax shares after each vesting event.